Yayın:
A new series of thiazole‐hydrazone hybrids for Akt‐targeted therapy of non‐small cell lung cancer

dc.contributor.authorOrujova, Turana
dc.contributor.authorÇiftçi, Gülşen Akalın
dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorMehlika Dilek Altıntop
dc.contributor.orcid0000-0002-6706-4901
dc.contributor.orcid0000-0002-3087-5145
dc.contributor.orcid0000-0001-5098-8967
dc.contributor.orcid0000-0003-0280-5550
dc.contributor.orcid0000-0002-8159-663X
dc.date.accessioned2025-11-13T09:47:43Z
dc.date.issued2022-12-05
dc.identifier.doihttps://doi.org/10.1002/ddr.22022
dc.identifier.endpage199
dc.identifier.issn0272-4391
dc.identifier.issue2
dc.identifier.openalexW4310710554
dc.identifier.startpage185
dc.identifier.urihttps://hdl.handle.net/11421/2215
dc.identifier.urihttps://doi.org/10.1002/ddr.22022
dc.identifier.volume84
dc.language.isoen
dc.relation.ispartofDrug Development Research
dc.rightsrestrictedAccess
dc.subjectThiazole
dc.subjectChemistry
dc.subjectCisplatin
dc.subjectProtein kinase B
dc.subjectApoptosis
dc.subjectIC50
dc.subjectA549 cell
dc.subjectCytotoxic T cell
dc.subjectStereochemistry
dc.subjectDocking (animal)
dc.subjectCell culture
dc.subjectMTT assay
dc.subjectCell growth
dc.subjectPharmacology
dc.subjectCytotoxicity
dc.subjectIn vitro
dc.subjectCancer research
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectChemotherapy
dc.subjectMedicine
dc.subject.sdg3
dc.titleA new series of thiazole‐hydrazone hybrids for Akt‐targeted therapy of non‐small cell lung cancer
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5074414242
local.authorid.openalexA5045943806
local.authorid.openalexA5100651829
local.authorid.openalexA5048968214

Dosyalar

Koleksiyonlar